Cargando…

Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study

BACKGROUND: Average postoperative follow-up intervals vary in patients undergoing hepatocellular carcinoma (HCC) resection because of limited evidence regarding the optimal interval. We aimed to compare the associations of long-versus short-interval follow-up with survival and recurrence in risk-str...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Wei, Zheng, Yun, Zou, Ruhai, Shen, Jingxian, Yang, Junping, Qiu, Jiliang, Tao, Qiang, Liu, Wenwu, Yang, Zhiwen, Zhang, Yuanping, Li, Binkui, Yuan, Yunfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993133/ https://www.ncbi.nlm.nih.gov/pubmed/29784036 http://dx.doi.org/10.1186/s40880-018-0296-x

Ejemplares similares

Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation
por: Liu, Wenwu, et al.
Publicado: (2018)

Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence
por: Tao, Qiang, et al.
Publicado: (2018)

Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis
por: Liu, Wenwu, et al.
Publicado: (2019)

Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study
por: Liu, Wenwu, et al.
Publicado: (2019)

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
por: Li, Binkui, et al.
Publicado: (2021)

Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study
por: He, Wei, et al.
Publicado: (2020)

The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis
por: He, Wei, et al.
Publicado: (2015)

Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: A long-term follow-up study
por: Zeng, Qing-An, et al.
Publicado: (2012)

Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
por: Liao, Yadi, et al.
Publicado: (2020)

Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
por: Wang, Chenwei, et al.
Publicado: (2021)

Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
por: Wang, Chenwei, et al.
Publicado: (2022)

SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition
por: Zhang, Yuanping, et al.
Publicado: (2021)

S100A9 Derived from Chemoembolization‐Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression
por: Zhong, Chengrui, et al.
Publicado: (2022)

Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature
por: Huang, Jun, et al.
Publicado: (2014)

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study
por: Yuan, Yichuan, et al.
Publicado: (2023)

Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma
por: Li, Binkui, et al.
Publicado: (2017)

NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3
por: Zhang, Yuanping, et al.
Publicado: (2022)

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
por: Lin, Zhu, et al.
Publicado: (2023)

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
por: Qiu, Jiliang, et al.
Publicado: (2011)

Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
por: Qiu, Zhiyu, et al.
Publicado: (2021)

METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
por: Bi, Fangfang, et al.
Publicado: (2023)

The efficacy and safety of long- versus short-interval transarterial chemoembolization in unresectable hepatocellular carcinoma
por: Yang, Zhi-Wen, et al.
Publicado: (2018)

HabibTM 4X-assisted resection versus clamp-crush resection for hepatocellular carcinoma: a propensity-matching study
por: Qiu, Jiliang, et al.
Publicado: (2016)

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer
por: Shi, Yunxing, et al.
Publicado: (2023)

Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis
por: Zhang, Yuanping, et al.
Publicado: (2020)

Identification of a molecular subtyping system associated with the prognosis of Asian hepatocellular carcinoma patients receiving liver resection
por: Ma, Xiaohua, et al.
Publicado: (2019)

Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort study
por: Medici, Marco, et al.
Publicado: (2016)

Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma
por: Li, Keren, et al.
Publicado: (2023)

Liver resection for hepatocellular carcinoma: case-matched analysis of laparoscopic versus open resection
por: Kim, Ho Hyun, et al.
Publicado: (2011)

Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
por: Alotaibi, Fahad E., et al.
Publicado: (2013)

Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome?
por: Li, Binkui, et al.
Publicado: (2010)

Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection
por: Merchant, Nishant, et al.
Publicado: (2011)

Insight into the gut microbiome dysbiosis in patients with liver failure after extended-hepatectomy
por: Xie, Feihu, et al.
Publicado: (2022)

The Impact of Time Interval between Hepatic Resection and Liver Transplantation on Clinical Outcome in Patients with Hepatocellular Carcinoma
por: Serenari, Matteo, et al.
Publicado: (2021)

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma
por: Zhou, Yanming, et al.
Publicado: (2010)

Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma
por: He, MinKe, et al.
Publicado: (2019)

Efficacy and safety of anatomic resection versus nonanatomic resection in patients with hepatocellular carcinoma: A systemic review and meta-analysis
por: Tan, Yifei, et al.
Publicado: (2017)

Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis
por: Yang, Daopeng, et al.
Publicado: (2020)

Comparative analysis of intraoperative radiofrequency ablation versus non-anatomical hepatic resection for small hepatocellular carcinoma: short-term result
por: Yune, Yongwoo, et al.
Publicado: (2015)

Laparoscopic versus open major liver resection for hepatocellular carcinoma: A case-matched analysis of short- and long-term outcomes
por: He, Aoxiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bfe9t1lbn4abrprjgj5101be0p